Regulis Consulting Ltd

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Regulis Consulting Ltd - overview

Established

2001

Location

-, Hertfordshire, UK

Primary Industry

Pharmaceuticals

About

Regulis Consulting Ltd specializes in providing expert consultancy services for the pharmaceutical, biotech, and medical device industries, focusing on compliance, regulatory affairs, and operational excellence. Regulis Consulting Ltd was founded in 2001 and is headquartered in the UK. The company offers consulting services tailored to the life sciences sector. In July 2020, Regulis was acquired by PharmaLex GmbH, a portfolio company of AUCTUS Capital Partners, with financial terms undisclosed.


The founder's specific history is not available, and there are no mentions of previous companies they may have founded. Regulis Consulting Ltd offers a comprehensive suite of specialized services aimed at the pharmaceutical, biotech, and medical device industries, focusing on compliance and operational excellence. Their core offerings include strategic consultancy, product development support, and lifecycle management, which encompasses regulatory affairs, pharmacovigilance, and quality management. These services are designed to assist clients in navigating complex regulatory environments and ensuring compliance with international standards.


Their diverse client base includes large pharmaceutical firms, biotech companies, and medical device manufacturers across North America, Europe, and Asia-Pacific. In the most recent fiscal year of 2023, Regulis Consulting Ltd reported zero revenue and zero EBITDA. Regulis Consulting Ltd is focused on expanding its service offerings and entering new geographic markets. The acquisition by PharmaLex is expected to facilitate this expansion due to increased resources and market reach.


As part of their growth strategy, the company aims to enhance its consultancy capabilities and support regulatory submissions across new regions. The strategic initiatives will leverage the resources from the acquisition deal finalized on July 16, 2020.


Current Investors

PharmaLex GmbH

Primary Industry

Pharmaceuticals

Sub Industries

Consulting Services, Bioinformatics, Pharmaceutical Research & Development

Website

www.regulis.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Regulis Consulting Ltd - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Regulis Consulting Ltd - financials

Fiscal Year EndedFeb 28, 2011Feb 29, 2012Feb 28, 2013Feb 28, 2014Feb 28, 2015Feb 28, 2016Feb 28, 2017Feb 28, 2018Feb 28, 2019Feb 28, 2020Feb 28, 2021Feb 28, 2022Sep 30, 2023
Revenue (USD)1,413,9721,310,5821,443,6201,527,606---------
% Revenue Growth (YoY)-(7.3%)10.2%5.8%---------
EBITDA (USD)339,202206,579444,6238,945---------
Operating Income (USD)335,953200,601438,8283,779---------
Operating Margin23.8%15.3%30.4%0.2%---------
% EBITDA Margin24.0%15.8%30.8%0.6%---------
NET Income (USD)266,084156,435343,2422,047---------
% Net Margin18.8%11.9%23.8%0.1%---------

Regulis Consulting Ltd - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedRegulis Consulting Ltd-

Displaying 1 - 1 of 1

Regulis Consulting Ltd - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.